YWYoshinobu Wakisaka

Yoshinobu Wakisaka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yoshinobu Wakisaka has a total of 122 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Independent Association of RNF213 p.R4810K With Extracranial Carotid Artery Disease Beyond Intracranial Atherosclerosis

    by Masamitsu Takashima, Takuya Kiyohara, Kuniyuki Nakamura, Yuichi Ozaki, Fumitaka Yoshino, Go Hashimoto, Masaoki Hidaka, Noriyuki Sahara, Fumi Irie, Yoshinobu Wakisaka, et al.

    BACKGROUND: The RNF213 p.R4810K variant, a susceptibility variant for moyamoya disease, has also been linked to intracranial atherosclerotic disease (ICAD). However, its association with extracranial carotid artery disease (ECAD), particularly whether this association is independent of concomitant ICAD and whether it differs by stenosis severity, remains unclear. METHODS: We conducted a multicenter registry-based observational study of patients with acute ischemic stroke (AIS) or transient ischemic attack enrolled in the Fukuoka Stroke Registry. Patients were genotyped for RNF213 p.R4810K and classified as noncarriers (G/G) or variant carriers (G/A or A/A). ECAD was defined as ≥50% stenosis or occlusion of the extracranial carotid arteries. Multivariable logistic regression was used to assess the association between RNF213 p.R4810K and ECAD after adjusting for vascular risk factors and ICAD, and stratified analyses were performed by ICAD status. ECAD severity was modeled ordinally (none, moderate, severe, and occlusion) using a partial proportional-odds model. RESULTS: Of 15 569 registry patients with AIS or transient ischemic attack, 13 994 were included in the present analysis after exclusions (mean age, 73±12 years; 59.5% men). The RNF213 p.R4810K variant was identified in 359 patients (2.6%). ECAD was present in 2181 patients (15.6%), including 78 variant carriers. Variant carriers had significantly higher odds of ECAD after adjustment for vascular risk factors and ICAD (odds ratio, 1.69 [95% CI, 1.29–2.22]). This association was consistent irrespective of ICAD status ( P heterogeneity =0.32). In severity analyses, the association strengthened stepwise with increasing ECAD severity; the largest effect estimate was for occlusion (odds ratio, 4.55 [95% CI, 2.81–7.38]). CONCLUSIONS: The RNF213 p.R4810K variant was associated with ECAD independent of concomitant ICAD and showed a graded association with ECAD severity. Extracranial disease expression may involve modifiers distinct from those driving ICAD.

  • Recurrent Severe Drug‐Induced Aseptic Meningitis due to Trimethoprim–Sulfamethoxazole Mimicking Ventriculitis‐Like MRI Findings in a Patient Receiving Anti–PD‐1 Therapy

    by Makoto Yazaki, Masaoki Hidaka, Satomi Mezuki, Takuya Kiyohara, Yuji Shono, Kuniyuki Nakamura, Yoshinobu Wakisaka, Koji Yamashita, Shunsuke Goto, Jun Mutaguchi, et al.

    Drug‐induced aseptic meningitis is a rare and usually self‐limiting condition. Although clinical and cerebrospinal fluid findings may resemble those of bacterial meningitis, brain magnetic resonance imaging findings are typically normal. An 80‐year‐old woman receiving anti–PD‐1 antibody therapy for bladder cancer developed severe meningitis with high fever and disturbed consciousness. Brain magnetic resonance imaging revealed findings suggestive of ventriculitis, strongly suggesting bacterial meningitis; however, blood and cerebrospinal fluid cultures obtained before the initiation of antibiotic therapy were negative. Two months earlier, the patient had experienced a similar episode of severe meningitis of unknown etiology. Careful review of the clinical course revealed that trimethoprim‐sulfamethoxazole had been administered shortly before the onset of both episodes. The patient was diagnosed with recurrent drug‐induced aseptic meningitis caused by trimethoprim‐sulfamethoxazole. Patients with drug‐induced aseptic meningitis rarely present with severe clinical and radiological features mimicking bacterial meningitis. Therefore, it should be considered in patients with culture‐negative meningitis, particularly those receiving immune checkpoint inhibitors.

  • Rhino-orbito-cerebral fungal infection associated with mixed Cladosporium halotolerans and Penicillium corylophilum, complicated by internal carotid artery occlusion and ischemic stroke: a case report

    by Masaoki Hidaka, Takuya Kiyohara, Makoto Yazaki, Kuniyuki Nakamura, Yoshinobu Wakisaka, Keijiro Ishikawa, Satomi Shiose, Ken Yamamoto, Yuka Yamashita, Nobuyuki Shimono, et al.

  • Open Access

    Endovascular therapy for isolated M2 occlusion in patients with ischemic stroke: A propensity score-matched analysis

    by Noriyuki Sahara, Go Hashimoto, Kuniyuki Nakamura, Fumi Irie, Takuya Kiyohara, Yoshinobu Wakisaka, Ryu Matsuo, Masahiro Kamouchi, Tetsuro Ago

    Introduction Endovascular therapy (EVT) is an established treatment for large vessel occlusion in patients with acute ischemic stroke; however, its efficacy for medium vessel occlusions, particularly isolated M2 segment occlusions, remains uncertain. As M2 occlusions are relatively proximal among medium vessel occlusions and can cause disabling neurological deficits, clarifying the role of EVT is clinically important. In this study, we aimed to evaluate the efficacy and safety of EVT compared with best medical management (BMM) in patients with acute isolated M2 occlusion using data from a multicentre registry. Methods We analysed the data of patients from a multicentre stroke registry who had an isolated M2 occlusion, had arrived within 24 hours of onset, and were functionally independent before stroke. Data on baseline demographics, vascular risk factors, stroke characteristics, and treatment were collected. Propensity score matching generated 100 well-balanced pairs of EVT- and BMM-treated patients. The primary outcomes were favourable functional outcomes (modified Rankin Scale [mRS] score of 0–2 or 0–1) and mortality at discharge and 3 months. The secondary outcomes included neurological improvement or deterioration and haemorrhagic complications during hospitalisation. Results Among 594 eligible patients (EVT, n = 118; BMM, n = 476), data from 100 matched pairs were analysed. At 3 months, good functional outcomes (mRS score of 0–2: 49% EVT vs. 46% BMM) and mortality (7% vs. 9%) were comparable, with consistent findings at discharge. EVT was associated with higher rates of any intracranial haemorrhage (46% vs. 21%), although the symptomatic intracranial haemorrhage rates were identical (5%). In exploratory subgroup analyses, a significant interaction with onset-to-door time was observed for mRS score of 0–2 (p = 0.03), whereas no significant interaction was detected for mRS score of 0–1 or mortality. Conclusion In this multicentre registry of patients with isolated M2 occlusion, EVT was not associated with superior functional outcomes or reduced mortality, compared with BMM. Although exploratory analyses suggested possible heterogeneity of treatment effect according to clinical factors, such as time from onset, these findings should be interpreted cautiously. Overall, the results highlight the heterogeneity of M2 occlusions and underscore the need for adequately powered randomised trials to inform individualised treatment decisions.

  • Open Access

    Association Between Higher Insulin Resistance and Poor Short‐Term Functional Outcome After Nonsurgical Intracerebral Hemorrhage

    by Takuya Kiyohara, Kuniyuki Nakamura, Fumi Irie, Yoshinobu Wakisaka, Ryu Matsuo, Masahiro Kamouchi, Tetsuro Ago

    Background: Insulin resistance has been implicated in unfavorable outcomes after ischemic stroke in recent studies, but its impact on functional outcomes after intracerebral hemorrhage (ICH) remains unclear. Methods: We analyzed 704 patients with nonsurgical ICH (mean age, 68 years) enrolled in the multicenter Fukuoka Stroke Registry who were treated conservatively and followed for 3 months. Insulin resistance was assessed using the homeostasis model assessment of insulin resistance (HOMA‐IR). There was a poor functional outcome, defined as a modified Rankin Scale score of 4 to 6 at 3 months. Logistic regression and restricted cubic spline analyses were performed. Sensitivity analyses estimated risk ratios and examined results in nondiabetic and nonobese patients. We also assessed the added predictive value of HOMA‐IR when incorporated into the max‐ICH score, a validated prognostic model, and the Fukuoka Stroke Registry ICH score, a developed model from the same registry, using the C statistic and 10‐fold cross‐validation. Results: Age‐ and sex‐adjusted odds ratios (ORs) for poor outcome increased significantly with higher HOMA‐IR ( P for trend 3.0. Adding HOMA‐IR modestly improved discrimination for both risk scores, with similar results in 10‐fold cross‐validation. Conclusions: Insulin resistance is independently associated with poor short‐term outcome after acute ICH. Incorporating HOMA‐IR improves prediction, identifying it as an early prognostic marker and a possible future therapeutic target.


  • Practical 1-2-3-4-Day Rule for Initiating Direct Oral Anticoagulants in Patients with Acute Ischemic Stroke after Endovascular Therapy: An Observational Study

    by Shunsuke Kimura, Noriyuki Sahara, Kuniyuki Nakamura, Tadataka Mizoguchi, Naoki Tagawa, Kota Mori, Yusuke Imamura, Takahiro Kuwashiro, Hiroshi Sugimori, Takuya Kiyohara, et al.

    Introduction: The optimal timing for initiating direct oral anticoagulants (DOACs) after endovascular therapy (EVT) for acute ischemic stroke (AIS) remains uncertain due to concerns regarding hemorrhagic complications. This study aimed to evaluate the safety and efficacy of early DOAC initiation guided by the “1-2-3-4-day” rule based on stroke severity in patients with non-valvular atrial fibrillation (NVAF) who underwent EVT. Methods: We analyzed data from the Fukuoka Stroke Registry, a multicenter cohort including patients with AIS with NVAF who underwent EVT between 2013 and 2023. Patients were classified into the early (DOAC initiated within 1–4 days) and non-early groups. The primary outcomes were in-hospital recurrent ischemic stroke and symptomatic intracranial hemorrhage (sICH) occurring more than 24 h after EVT. The secondary outcome was a good functional outcome at 3 months (modified Rankin Scale score of 0–2). Multivariable Poisson regression and inverse probability weighting (IPW) were used for adjustment. Results: Among the 397 patients analyzed for safety outcomes and 262 for functional outcomes, early DOAC initiation was not associated with increased risk of recurrent ischemic stroke or sICH. The proportion of patients with good functional outcome was significantly higher in the early group than in the non-early group (63.8% vs. 42.2%; adjusted risk ratio, 1.33; 95% CI, 1.06–1.66; p = 0.02). Findings remained consistent across subgroups and sensitivity analyses using IPW. Conclusions: Early DOAC initiation following EVT based on the “1-2-3-4-day” rule was not associated with increased hemorrhagic risk; rather, it was associated with improved functional outcomes, supporting its feasibility.

  • Association between Ambient Temperature and Risk of Ischaemic Stroke: An Observational Cohort Study

    by Ryu Matsuo, Haruhiko Motomura, Fumi Irie, Yoshinobu Wakisaka, Tetsuro Ago, Masahiro Kamouchi, Takanari Kitazono

    Introduction: The influence of ambient temperature on the risk of stroke has remained unclear, particularly in relation to stroke subtypes. This study aimed to investigate the association between ambient temperature and the risk of ischaemic stroke from various aetiologies. Methods: We investigated the onset of acute ischaemic stroke in the prospective stroke registry conducted from October 2007 to September 2019 in Fukuoka, Japan. Stroke aetiology was classified into cardioembolism (CE), large-artery atherosclerosis (LAA), small-vessel occlusion (SVO), and other aetiologies. Hourly, maximum, and minimum temperature data were obtained from the Japan Meteorological Agency. After controlling for the non-linear and delayed effects of daily average temperature, we employed a quasi-Poisson generalised additive model with the natural logarithm of daily stroke counts as a function of predictors, including temperature metrics and humidity. Results: A total of 17,755 patients with acute ischaemic stroke (mean age ± SD: 73.1 ± 12.6 years; 41.4% female) were included in the analysis. Lower temperatures were associated with an increased risk of CE and LAA but not with that of SVO. Conversely, higher temperatures were associated with a decreased risk of CE, whereas no association was found with LAA or SVO. The association was observed within 5 days before stroke onset for LAA but after a longer period for CE. The risk of CE increased with rising variability in daily temperature preceding stroke onset. Conclusion: We observed distinct associations between ambient temperature and the risk of ischaemic stroke, contingent upon stroke aetiology, temperature levels, exposure duration, and patient characteristics.


  • Clinical outcomes following acute ischaemic stroke in patients with comorbid cancer

    by Noriko Sato, Fumi Kiyuna, Kayo Wakisaka, Yuichiro Ohya, Kana Ueki, Sohei Yoshimura, Kuniyuki Nakamura, Jun Hata, Yoshinobu Wakisaka, Tetsuro Ago, et al.

    Introduction: The prevalence of comorbid cancer is higher in patients with ischaemic stroke than in the general population, and recent studies have attempted to clarify the relationship between the two. We observed that the evidence for the impact of comorbid cancer on post-stroke clinical outcomes was not established and aimed to investigate it among patients with new-onset acute ischaemic stroke. Methods: We evaluated 13,345 patients with acute ischaemic stroke who were functionally independent before onset (modified Rankin Scale [mRS] score of 0–2) and admitted to one of the seven stroke centres in Fukuoka, Japan, between June 2007 and September 2019. A total of 13,047 patients were included in the analyses after excluding those with missing potential confounders (n=13) or loss to follow-up (n=298). Comorbid cancer was diagnosed based on previous history or newly identified cancer during hospitalisation for the index stroke. Multivariable-adjusted Poisson regression analyses were conducted to assess the association of comorbid cancer with post-stroke outcomes: clinically assessed poor functional outcomes (mRS score, 3–6), functional dependency (mRS score, 3–5), and mortality (mRS score, 6) at 3 months after stroke onset. Results: Of 13,047 patients (aged 71.1±12.3 years, 62.8% men) with acute ischaemic stroke, 2,027 (15.6%) had comorbid cancer. Among those with no cancer, 24.0% recorded poor functional outcomes; with non-active cancer, 30.7%; and with active cancer, 46.1%. The risk ratios (95% confidence interval) for poor functional outcome at 3 months increased with active cancer (1.50 [1.37–1.65] vs. no cancer) and recently diagnosed cancer (7 months–4 years: 1.43 [1.28–1.59], ≤6 months: 1.53 [1.36–1.72]) after adjusting for potential confounders. These associations were observed for both 3-month functional dependency and mortality. No significant heterogeneity was observed in these associations across sex, nutritional status, inflammatory status, or coagulation status, except for age and stroke severity. The strongest association with 3-month poor functional outcome was observed for pancreatic cancer, followed by gallbladder and biliary tract, liver, and colon cancers. Conclusions: Comorbid cancer is likely to be independently associated with unfavourable outcomes in patients with acute ischaemic stroke.


  • Functional Outcome Prediction in Japanese Patients with Nonsurgical Intracerebral Hemorrhage: The FSR ICH Score

    by Takuya Kiyohara, Ryu Matsuo, Fumi Irie, Kuniyuki Nakamura, Jun Hata, Yoshinobu Wakisaka, Takanari Kitazono, Masahiro Kamouchi, Tetsuro Ago, Investigators for Fukuoka Stroke Registry

    Introduction: There has been limited research on predicting the functional prognosis of patients with nonsurgical intracerebral hemorrhage (ICH) from the acute stage. The aim of this study was to develop a risk prediction model for the natural course in patients with nonsurgical ICH and to evaluate its performance using a multicenter hospital-based prospective study of stroke patients in Japan. Methods: We consecutively registered a total of 1,017 patients with acute ICH (mean age, 68 years) who underwent conservative treatment and followed them up for 3 months. The study outcome was a poor functional outcome (modified Rankin Scale score, 4–6) at 3 months after ICH onset. To develop the risk prediction model for natural course in patients with nonsurgical ICH, we included the following clinical common factors assessed on admission in daily clinical practice for ICH: age, sex, medical history (hypertension, diabetes mellitus, dyslipidemia, pre-stroke dementia, previous stroke, coronary artery disease, smoking status, alcohol drinking status, oral anticoagulation, and antiplatelet medication), admission status (time from onset to admission, systolic blood pressure, diastolic blood pressure, pulse pressure, plasma glucose levels, severity of the stroke), and neuroradiologic data (ICH location, intraventricular hemorrhage, and hematoma volume). The risk prediction model for poor functional outcome was developed using logistic regression analysis. In addition, the risk prediction model was translated into a point-based simple risk score (FSR ICH score) using the approach in the Framingham Heart Study. Results: At 3 months after the ICH onset, 323 (31.8%) patients developed a poor functional outcome. Age, diabetes mellitus, pre-stroke dementia, NIHSS score on admission, intraventricular hemorrhage, and hematoma volume were included in the risk prediction model. This model demonstrated excellent discrimination (C statistic = 0.884 [95% confidence interval, 0.863–0.905]; optimism-corrected C statistic based on 200 bootstrap samples = 0.877) and calibration (Hosmer-Lemeshow goodness-of-fit test: p = 0.72). The FSR ICH score, a point-based simple risk score, also showed excellent discrimination, with a C statistic of 0.882 (95% CI: 0.861–0.903). Conclusions: We developed a new risk prediction model for 3-month poor functional outcome in patients with nonsurgical ICH using a multicenter hospital-based prospective study in Japan. The current risk prediction model has the potential to be a useful tool for estimating the natural course in patients with nonsurgical ICH, aiding in making treatment decisions, including surgical options, early formulation of rehabilitation plans, and efficient utilization of medical resources.


  • Open Access

    Predictive Performance of Machine Learning–Based Models for Poststroke Clinical Outcomes in Comparison With Conventional Prognostic Scores: Multicenter, Hospital-Based Observational Study

    by Fumi Irie, Koutarou Matsumoto, Ryu Matsuo, Yasunobu Nohara, Yoshinobu Wakisaka, Tetsuro Ago, Naoki Nakashima, Takanari Kitazono, Masahiro Kamouchi

    Background: Although machine learning is a promising tool for making prognoses, the performance of machine learning in predicting outcomes after stroke remains to be examined. Objective: This study aims to examine how much data-driven models with machine learning improve predictive performance for poststroke outcomes compared with conventional stroke prognostic scores and to elucidate how explanatory variables in machine learning–based models differ from the items of the stroke prognostic scores. Methods: We used data from 10,513 patients who were registered in a multicenter prospective stroke registry in Japan between 2007 and 2017. The outcomes were poor functional outcome (modified Rankin Scale score >2) and death at 3 months after stroke. Machine learning–based models were developed using all variables with regularization methods, random forests, or boosted trees. We selected 3 stroke prognostic scores, namely, ASTRAL (Acute Stroke Registry and Analysis of Lausanne), PLAN (preadmission comorbidities, level of consciousness, age, neurologic deficit), and iScore (Ischemic Stroke Predictive Risk Score) for comparison. Item-based regression models were developed using the items of these 3 scores. The model performance was assessed in terms of discrimination and calibration. To compare the predictive performance of the data-driven model with that of the item-based model, we performed internal validation after random splits of identical populations into 80% of patients as a training set and 20% of patients as a test set; the models were developed in the training set and were validated in the test set. We evaluated the contribution of each variable to the models and compared the predictors used in the machine learning–based models with the items of the stroke prognostic scores. Results: The mean age of the study patients was 73.0 (SD 12.5) years, and 59.1% (6209/10,513) of them were men. The area under the receiver operating characteristic curves and the area under the precision-recall curves for predicting poststroke outcomes were higher for machine learning–based models than for item-based models in identical populations after random splits. Machine learning–based models also performed better than item-based models in terms of the Brier score. Machine learning–based models used different explanatory variables, such as laboratory data, from the items of the conventional stroke prognostic scores. Including these data in the machine learning–based models as explanatory variables improved performance in predicting outcomes after stroke, especially poststroke death. Conclusions: Machine learning–based models performed better in predicting poststroke outcomes than regression models using the items of conventional stroke prognostic scores, although they required additional variables, such as laboratory data, to attain improved performance. Further studies are warranted to validate the usefulness of machine learning in clinical settings.